The National Institute for Health and Care Excellence (NICE) has published medical technology guidance recommending the use of Boston Scientific’s cardiac resynchronization therapy defibrillators (CRT-D) powered by EnduraLife battery technology, for treating patients with heart failure.
NICE concluded that the extended battery life observed with Boston Scientific EnduraLife-powered CRT-Ds is likely to reduce the number of avoidable replacement procedures a patient may have to undergo.
The NICE medical technologies advisory committee found that 16 independent clinical and economic studies supported adoption and concluded that the EnduraLife-powered CRT-Ds have longer battery life compared with other CRT-Ds reviewed.
The EnduraLife battery has nearly twice the capacity of standard batteries and it is smaller. — Cynthia Jessup